-transparent.png){kind=logo}
The insulin-like growth factors (IGF)-I and IGF-II are peptides with structural homology to insulin and potent mitogenic and anabolic actions in vitro and in vivo. IGF-I levels are growth hormone (GH)-dependent and vary strikingly with age. IGF-I levels are typically low in infancy and childhood, increase dramatically during puberty, and then gradually decline with advancing age. Whether age-associated changes in GH production or sex steroid secretion, or other unknown factors, cause diminished IGF production in the elderly remains to be determined. In the brain, IGF-II appears to be the most prevalent IGF, but a truncated form of IGF-I also has been recognized. IGF actions are mediated by binding to a family of receptors, which includes the insulin receptor, the structurally homologous type I IGF receptor, and the IGF-II/M-6P receptor, all of which are found in the central nervous system. Additionally, the IGFs bind with high affinity to a family of IGF-binding proteins (IGFBPs). Of the six known IGFBPs, IGFBP-2 appears to be the major one in the mammalian brain and is a major component of CSF. Immunoreactive IGFBP-2 has been identified in astrocytes, and its mRNA has been identified in fetal and adult brain and choroid plexus. The IGFBPs transport the IGFs in serum and other body fluids and appear to regulate IGF access to receptors. In vivo regulation of IGFBPs includes tissue-specific proteases, which cleave specific IGFBPs, altering their affinities for IGF peptides.(ABSTRACT TRUNCATED AT 250 WORDS)
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
November 2005,
Gynecologic oncology,
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
January 1992,
Reproduction, fertility, and development,
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
January 1992,
Annali dell'Istituto superiore di sanita,
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
February 1998,
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society,
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
January 1987,
Gut,
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
December 1987,
Endocrinology and metabolism clinics of North America,
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
January 1991,
Acta paediatrica Scandinavica. Supplement,
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
January 2000,
Drugs & aging,
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
December 2011,
Growth factors (Chur, Switzerland),
P Cohen, and
I Ocrant, and
P J Fielder, and
E K Neely, and
S E Gargosky, and
C I Deal, and
G P Ceda, and
O Youngman, and
H Pham, and
G Lamson
August 1993,
Molecular reproduction and development,
